Ben Dubin

Managing Partner at Asset Management Co.

Ben Dubin

Ben Dubin

Managing Partner at Asset Management Co.

Overview
Career Highlights

Asset Management Co.
Asset Management Ventures LLC
Los Altos Technology

RelSci Relationships

1539

Number of Boards

13

Contact Data
Trying to get in touch with Ben Dubin? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Ben Dubin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Prime Advantage Corp.

Relationship likelihood: Strong

Founding Partner at Asset Management Co.

Relationship likelihood: Strong

Partner at Asset Management Ventures LLC

Relationship likelihood: Strong

Managing Director at Motus Ventures

Relationship likelihood: Strong

Trustee at Montalvo Arts Center

Relationship likelihood: Strong

Finance Chair at Montalvo Arts Center

Relationship likelihood: Strong

Investor & Advisor at WellDoc, Inc.

Relationship likelihood: Strong

Founder & Chief Executive Officer at Skire, Inc.

Relationship likelihood: Strong

Community Affairs Manager at Asset Management Co.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Glenwood West

Relationship likelihood: Strong

Paths to Ben Dubin
Potential Connections via
Relationship Science
You
Ben Dubin
Managing Partner at Asset Management Co.
Education
MBA

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

BS in Computer Engineering

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Memberships
Member
Current
Member
Current

Churchill Club was founded by Rich Karlgaard, now publisher of Forbes magazine, and Tony Perkins, now Chairman and Editor-in-Chief of Red Herring Communications. Together, Tony, Rich, and a group of friends from the Ed Zschau senate campaign, built an organization dedicated to producing programs where "important people say important things". As a Churchill Club speaker, then Arkansas governor Bill Clinton suggested that America needs a nation of Churchills-leaders rather than followers.

Member
Current

IEEE Computer Society operates a society of institute electrical and electronics engineers. It services include digital library, publication, and conferences and events. The company was founded in 1946 and is headquartered in Washington, DC.

Career History
Managing Partner
1998 - Current

Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA.

Co-Founder
Current
Investor
Current

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Based on proprietary lipid conjugate technology, the company's two clinical stage compounds have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. CMX001 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofovir-diphosphate. Its broad spectrum activity against double-stranded DNA (dsDNA) viruses without the myelotoxicity and nephrotoxicity of current agents has the potential to improve outcomes for immunosuppressed patients. Chimerix's second clinical-stage antiviral compound, CMX157 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent tenofovir-diphosphate. It has the potential to directly address several limitations of current HIV and HBV therapies. Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, influenza, malaria and other global public health needs.

Boards & Committees
Director
Prior - 2012

Athena Design Systems, Inc. provides software tools and manufactures IC optimization tools that enable the nanometer design. The company was founded in 2003 by Dimitris Fotakis and is headquartered in Santa Clara, CA

Director
2004 - 2008

KonaWare, Inc. provides mobile software solutions. Its products include transport and fleet LVM applications and electronic driver logs. It provides services in the areas of supply chain, education, transportation and distribution, and workforce management. The company was founded by Jim DiSanto, Wesley Cheng, and Gary Portney in 1999 and is headquartered in Menlo Park, CA.

Director
Prior

Corrigo, Inc. provides cloud-based software and services for facilities maintenance. Its software is used in multiple industries, including restaurants, retail, property management, hospitality, health care, homebuilding, manufacturing and distribution. The company was founded by Vadim Zhuk, Richard Michaux, David Rainton and Gregory J. Roufa in 1999 and is headquartered in Tualatin, OR.

Trustee
Tenure Unconfirmed

Montalvo Arts Center operates as a non-profit center for the arts. The company is headquartered in Saratoga, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $2,499
2018

TO CHANGE STUDENT LIVES BY RAISING AND INVESTING FUNDS TO SUPPORT THE EDUCATIONAL EXCELLENCE OF FOOTHILL COLLEGE AND DE-ANZA COLLEGE.

Investments
Details Hidden

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Based on proprietary lipid conjugate technology, the company's two clinical stage compounds have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. CMX001 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofovir-diphosphate. Its broad spectrum activity against double-stranded DNA (dsDNA) viruses without the myelotoxicity and nephrotoxicity of current agents has the potential to improve outcomes for immunosuppressed patients. Chimerix's second clinical-stage antiviral compound, CMX157 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent tenofovir-diphosphate. It has the potential to directly address several limitations of current HIV and HBV therapies. Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, influenza, malaria and other global public health needs.

Details Hidden

Corrigo, Inc. provides cloud-based software and services for facilities maintenance. Its software is used in multiple industries, including restaurants, retail, property management, hospitality, health care, homebuilding, manufacturing and distribution. The company was founded by Vadim Zhuk, Richard Michaux, David Rainton and Gregory J. Roufa in 1999 and is headquartered in Tualatin, OR.

Details Hidden

Skire, Inc. provides capital program, facilities, real estate, and project portfolio management software. The company was founded in 1998 by Massy Mehdipour and is headquartered in Las Vegas, NV.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ben Dubin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ben Dubin's profile does not indicate a business or promotional relationship of any kind between RelSci and Ben Dubin.